Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 1.24 USD Market Closed
Market Cap: 27.3m USD
Have any thoughts about
Enlivex Therapeutics Ltd?
Write Note

Intrinsic Value

ENLV's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one ENLV stock under the Base Case scenario is 1.18 USD. Compared to the current market price of 1.24 USD, Enlivex Therapeutics Ltd is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENLV Intrinsic Value
1.18 USD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Enlivex Therapeutics Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ENLV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ENLV?
Bearish
Neutral
Bullish

Fundamental Analysis

1.24 USD
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Enlivex Therapeutics Ltd
IL
Biotechnology
Market Cap
25.9m USD
IPO
Jul 30, 2014
Employees
50
Israel
Market Cap
25.9m USD
Industry
Biotechnology
IPO
Jul 30, 2014
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Enlivex Therapeutics Ltd

Provide an overview of the primary business activities
of Enlivex Therapeutics Ltd.

What unique competitive advantages
does Enlivex Therapeutics Ltd hold over its rivals?

What risks and challenges
does Enlivex Therapeutics Ltd face in the near future?

Summarize the latest earnings call
of Enlivex Therapeutics Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enlivex Therapeutics Ltd.

Provide P/S
for Enlivex Therapeutics Ltd.

Provide P/E
for Enlivex Therapeutics Ltd.

Provide P/OCF
for Enlivex Therapeutics Ltd.

Provide P/FCFE
for Enlivex Therapeutics Ltd.

Provide P/B
for Enlivex Therapeutics Ltd.

Provide EV/S
for Enlivex Therapeutics Ltd.

Provide EV/GP
for Enlivex Therapeutics Ltd.

Provide EV/EBITDA
for Enlivex Therapeutics Ltd.

Provide EV/EBIT
for Enlivex Therapeutics Ltd.

Provide EV/OCF
for Enlivex Therapeutics Ltd.

Provide EV/FCFF
for Enlivex Therapeutics Ltd.

Provide EV/IC
for Enlivex Therapeutics Ltd.

Show me price targets
for Enlivex Therapeutics Ltd made by professional analysts.

What are the Revenue projections
for Enlivex Therapeutics Ltd?

How accurate were the past Revenue estimates
for Enlivex Therapeutics Ltd?

What are the Net Income projections
for Enlivex Therapeutics Ltd?

How accurate were the past Net Income estimates
for Enlivex Therapeutics Ltd?

What are the EPS projections
for Enlivex Therapeutics Ltd?

How accurate were the past EPS estimates
for Enlivex Therapeutics Ltd?

What are the EBIT projections
for Enlivex Therapeutics Ltd?

How accurate were the past EBIT estimates
for Enlivex Therapeutics Ltd?

Compare the revenue forecasts
for Enlivex Therapeutics Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enlivex Therapeutics Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enlivex Therapeutics Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enlivex Therapeutics Ltd compared to its peers.

Compare the P/E ratios
of Enlivex Therapeutics Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Enlivex Therapeutics Ltd with its peers.

Analyze the financial leverage
of Enlivex Therapeutics Ltd compared to its main competitors.

Show all profitability ratios
for Enlivex Therapeutics Ltd.

Provide ROE
for Enlivex Therapeutics Ltd.

Provide ROA
for Enlivex Therapeutics Ltd.

Provide ROIC
for Enlivex Therapeutics Ltd.

Provide ROCE
for Enlivex Therapeutics Ltd.

Provide Gross Margin
for Enlivex Therapeutics Ltd.

Provide Operating Margin
for Enlivex Therapeutics Ltd.

Provide Net Margin
for Enlivex Therapeutics Ltd.

Provide FCF Margin
for Enlivex Therapeutics Ltd.

Show all solvency ratios
for Enlivex Therapeutics Ltd.

Provide D/E Ratio
for Enlivex Therapeutics Ltd.

Provide D/A Ratio
for Enlivex Therapeutics Ltd.

Provide Interest Coverage Ratio
for Enlivex Therapeutics Ltd.

Provide Altman Z-Score Ratio
for Enlivex Therapeutics Ltd.

Provide Quick Ratio
for Enlivex Therapeutics Ltd.

Provide Current Ratio
for Enlivex Therapeutics Ltd.

Provide Cash Ratio
for Enlivex Therapeutics Ltd.

What is the historical Revenue growth
over the last 5 years for Enlivex Therapeutics Ltd?

What is the historical Net Income growth
over the last 5 years for Enlivex Therapeutics Ltd?

What is the current Free Cash Flow
of Enlivex Therapeutics Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enlivex Therapeutics Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Enlivex Therapeutics Ltd

Current Assets 28.6m
Cash & Short-Term Investments 25.9m
Other Current Assets 2.6m
Non-Current Assets 3.3m
PP&E 2m
Other Non-Current Assets 1.3m
Current Liabilities 2.8m
Accounts Payable 303k
Accrued Liabilities 2.5m
Non-Current Liabilities 499k
Other Non-Current Liabilities 499k
Efficiency

Earnings Waterfall
Enlivex Therapeutics Ltd

Revenue
0 USD
Operating Expenses
-18.7m USD
Operating Income
-18.7m USD
Other Expenses
-3.6m USD
Net Income
-22.3m USD

Free Cash Flow Analysis
Enlivex Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ENLV Profitability Score
Profitability Due Diligence

Enlivex Therapeutics Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Enlivex Therapeutics Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ENLV Solvency Score
Solvency Due Diligence

Enlivex Therapeutics Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Enlivex Therapeutics Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENLV Price Targets Summary
Enlivex Therapeutics Ltd

There are no price targets for ENLV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ENLV?

Click here to dive deeper.

Dividends

Enlivex Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ENLV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one ENLV stock?

The intrinsic value of one ENLV stock under the Base Case scenario is 1.18 USD.

Is ENLV stock undervalued or overvalued?

Compared to the current market price of 1.24 USD, Enlivex Therapeutics Ltd is Overvalued by 5%.

Back to Top